Kebuzone: Difference between revisions
Appearance
Content deleted Content added
CarsonGell (talk | contribs) No edit summary |
Changing short description from "Chemical compound" to "NSAID anti-inflammatory medication" |
||
(8 intermediate revisions by 8 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|NSAID anti-inflammatory medication}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
| Verifiedfields = changed |
||
Line 44: | Line 45: | ||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=19 | H=18 | N=2 | O=3 |
| C=19 | H=18 | N=2 | O=3 |
||
| molecular_weight = 322.35782 g/mol |
|||
| smiles = CC(=O)CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3 |
| smiles = CC(=O)CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3 |
||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
||
Line 52: | Line 52: | ||
}} |
}} |
||
'''Kebuzone''' (or '''ketophenylbutazone''') is a [[nonsteroidal anti-inflammatory drug]] (NSAID)<ref name="AustriaCodex">{{cite book|title=Austria-Codex|at=Rheumesser 3 ml-Ampullen|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2018|language=German}}</ref> |
'''Kebuzone''' (or '''ketophenylbutazone''') is a [[nonsteroidal anti-inflammatory drug]] (NSAID) that is used for the treatment of inflammatory conditions such as [[thrombophlebitis]] and [[rheumatoid arthritis]] (RA).<ref name="AustriaCodex">{{cite book|title=Austria-Codex|at=Rheumesser 3 ml-Ampullen|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2018|language=German}}</ref><ref>{{Cite web|url=https://drugs.ncats.io/drug/4VD83UL6Y6| work = NCATS Inxight: Drugs | title = KEBUZONE |language=en|access-date=2019-02-27}}</ref><ref>{{cite book | vauthors = Aronson JK | chapter = Kebuzone |title=Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions |date=2016 |location=Amsterdam |isbn=978-0-444-53716-4 |page=405 |edition=Sixteenth | chapter-url=https://books.google.com/books?id=NOKoBAAAQBAJ&dq=Kebuzone&pg=RA3-PA405}}</ref> |
||
==References== |
==References== |
||
Line 62: | Line 62: | ||
[[Category:Ketones]] |
[[Category:Ketones]] |
||
[[Category:Pyrazolidindiones]] |
[[Category:Pyrazolidindiones]] |
||
[[Category:Nonsteroidal anti-inflammatory drugs]] |
|||
Latest revision as of 00:18, 27 October 2023
![]() | |
Clinical data | |
---|---|
Routes of administration | intramuscular |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 70–100 hours |
Excretion | renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.011.560 |
Chemical and physical data | |
Formula | C19H18N2O3 |
Molar mass | 322.364 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Kebuzone (or ketophenylbutazone) is a nonsteroidal anti-inflammatory drug (NSAID) that is used for the treatment of inflammatory conditions such as thrombophlebitis and rheumatoid arthritis (RA).[1][2][3]
References
[edit]- ^ Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. 2018. Rheumesser 3 ml-Ampullen.
- ^ "KEBUZONE". NCATS Inxight: Drugs. Retrieved 2019-02-27.
- ^ Aronson JK (2016). "Kebuzone". Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions (Sixteenth ed.). Amsterdam. p. 405. ISBN 978-0-444-53716-4.
{{cite book}}
: CS1 maint: location missing publisher (link)